178 related articles for article (PubMed ID: 21263148)
1. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
Nørgaard M; Jensen AØ; Engebjerg MC; Farkas DK; Thomsen RW; Cha S; Zhao S; Sørensen HT
Blood; 2011 Mar; 117(13):3514-20. PubMed ID: 21263148
[TBL] [Abstract][Full Text] [Related]
2. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.
Frederiksen H; Maegbaek ML; Nørgaard M
Br J Haematol; 2014 Jul; 166(2):260-7. PubMed ID: 24690142
[TBL] [Abstract][Full Text] [Related]
3. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
4. Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study.
Mannering N; Hansen DL; Pottegård A; Frederiksen H
Transfusion; 2023 Feb; 63(2):415-426. PubMed ID: 36601709
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities in patients with persistent or chronic immune thrombocytopenia.
Enger C; Bennett D; Forssen U; Fogarty PF; McAfee AT
Int J Hematol; 2010 Sep; 92(2):289-95. PubMed ID: 20652840
[TBL] [Abstract][Full Text] [Related]
6. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
[TBL] [Abstract][Full Text] [Related]
7. Geographic disparities in the care and outcomes in adult chronic immune thrombocytopenia.
Wall E; Podstawka J; Patterson JM; Bolster L; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2023 May; 225():87-94. PubMed ID: 37031501
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study.
Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M
Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study.
Kwiatkowska A; Radkowiak D; Wysocki M; Torbicz G; Gajewska N; Lasek A; Kulawik J; Budzyński A; Pędziwiatr M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31003557
[TBL] [Abstract][Full Text] [Related]
11. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
[TBL] [Abstract][Full Text] [Related]
12. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP).
Enger C; Bennett D; Dawson KL; Aivado MA; Theodore D; McAfee AT
Ann Hepatol; 2011; 10(2):188-95. PubMed ID: 21502681
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.
Bennett D; Hodgson ME; Shukla A; Logie JW
Adv Ther; 2011 Dec; 28(12):1096-104. PubMed ID: 22139790
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
Adly AA; Ragab IA; Ismail EA; Farahat MM
Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
[TBL] [Abstract][Full Text] [Related]
17. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
Kjaersgaard M; Edslev PW; Rosthøj S
Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
20. High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.
Kim CY; Lee EH; Yoon HS
Yonsei Med J; 2016 Jan; 57(1):127-31. PubMed ID: 26632392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
